跳至主要内容
临床试验/NCT00994708
NCT00994708已完成3 期

The Effect of Esomeprazole and Nissen Fundoplication on Bronchial Responsiveness, Quality of Life, Exhaled Nitric Oxide and Pulmonary Function in Patients With Gastroesophageal Reflux Disease

Tampere University Hospital2 个研究点 分布在 1 个国家开始时间: 2004年12月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
2

研究概览

简要总结

Evaluate the prevalence of bronchial responsiveness (BHR) among patients with gastroesophageal reflux disease (GERD).

Investigate correlation between bronchial reactivity and the severity of GERD, and similarly investigate the correlation between exhaled nitric oxide (NO) and the severity of GERD.

Compare the effects of esomeprazole 40 mg twice daily and Nissen fundoplication on bronchial reactivity, exhaled NO, pulmonary function and quality of life.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Over 18 of age
  • Diagnosis of gastroesophageal reflux disease
  • Compliance to perform methacholine inhalation challenge (judged by the investigator)

排除标准

  • Known allergy to esomeprazole or any other PPI
  • Use of systemic corticosteroids within 3 weeks before any study visit
  • Pregnancy (in a written informed consent patients are asked to assure that they are not pregnant and they are also told to immediately stop the study medication if they become pregnant during the study)
  • Incapability to keep a 3-week washout with usual antireflux medication prior to the first visit
  • Regular use of PPI or H2-RA medication 3 months after fundoplication

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

The Effect of Esomeprazole and Fundoplication on... | 临床试验